NCT06828731View on ClinicalTrials.gov

Evaluation of Empagliflozin vs Standard Care in Veterans With Prediabetes

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

June 30, 2026

Conditions
Prediabetes
Interventions
DRUG

Empagliflozin 10mg daily

This intervention will assess recruitment and retention (feasibility trial).

OTHER

Lifestyle education

This intervention is considered standard care for prediabetes.

Trial Locations (1)

28805

RECRUITING

Charles George VA Medical Center, Asheville

All Listed Sponsors
lead

Charles George VA Medical Center

FED